10-QThe Record
Janux Therapeutics, Inc. files 10-Q
Filed Nov 7, 2023 · 2y ago · Accession 0000950170-23-060288
Plain English
Quarterly report — three-month financials and management discussion.
Read the source below for the full document.
Filing details
- Company
- Janux Therapeutics, Inc.
- Ticker
- JANX
- CIK
- 1817713
- Form type
- 10-Q
- Filing date
- Nov 7, 2023
- Report date
- Sep 30, 2023
- Document
- janx-20230930.htm
- Size
- 10.3 MB